Role of spinal MRI in the follow-up of children treated for medulloblastoma

Cancer

Volumn 107, Issue 6, 2006, Pages 1340-1347

  Bartels, Ute ^a   Shroff, Manohar ^a   Sung, Lillian ^a   Dag Ellams, Ugo ^a   Laperriere, Normand ^b   Rutka, James ^a   Bouffet, Eric ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Medulloblastoma; Recurrence; Spinal magnetic resonance imaging (MRI); Surveillance imaging

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILD; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LEPTOMENINX; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE; POSTERIOR FOSSA; PREDICTION; PRIORITY JOURNAL; SPINAL MAGNETIC RESONANCE IMAGING; SYMPTOMATOLOGY;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; REPRODUCIBILITY OF RESULTS; SPINAL CORD;

EID: 33749036299     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22129     Document Type: Article

References (25)

1. Torres CF, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med. 1994;330:892-895.
2. Lindsley KL. Surveillance scanning of children with medulloblastoma. N Engl J Med. 1994;331:483.
3. Friedman HS, Kun LE. More on surveillance of children with medulloblastoma. N Engl J Med. 1995;332:191.
4. Mendel E, Levy ML, Raffel C, et al. Surveillance imaging in children with primitive neuroectodermal tumors. Neurosurgery. 1996;38:692-694.
5. Bouffet E, Doz F, Demaille MC, et al. Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse? Br J Cancer. 1998;77:1321-1326.
6. Kramer ED, Vezina LG, Packer RJ, Fitz CR, Zimmerman RA, Cohen MD. Staging and surveillance of children with central nervous system neoplasms: recommendations of the Neurology and Tumor Imaging Committees of the Children's Cancer Group. Pediatr Neurosurg. 1994;20:254-262.
7. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003;21:1581-1591.
8. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol. 1999;17:2127-2136.
9. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastomas. Radiology. 1969;93:1351-1359.
10. Minn AY, Pollock BH, Garzarella L, et al. Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study. J Clin Oncol. 2001;19:4135-4140.
11. Altinors N, Senveli E, Arda N, et al. Spinal extradural metastasis from a medulloblastoma. Neurochirurgia (Stuttg). 1989;32:84-86.
12. Hughes EN, Shillito J, Sallan SE, Loeffler JS, Cassady JR, Tarbell NJ. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer. 1988;61:1992-1998.
13. Steinbok P, Hentschel S, Cochrane DD, Kestle JR. Value of postoperative surveillance imaging in the management of children with some common brain tumors. J Neurosurg. 1996;84:726-732.
14. Wootton-Gorges SL, Foreman NK, Albano EA, et al. Pattern of recurrence in children with midline posterior fossa malignant neoplasms. Pediatr Radiol. 2000;30:90-93.
15. Brand WN, Schneider PA, Tokars RP. Long-term results of a pilot study of low dose cranial-spinal irradiation for cerebellar medulloblastoma. Int J Radiat Oncol Biol Phys. 1987;13:1641-1645.
16. Saunders DE, Hayward RD, Phipps KP, Chong WK, Wade AM. Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long? J Neurosurg. 2003;99:280-286.
17. Kortmann RD, Kuhl J, Timmermann B, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys. 2000;46:269-279.
18. Yalcin B, Buyukpamukcu M, Akalan N, Cila A, Kutluk MT, Akyuz C. Value of surveillance imaging in the management of medulloblastoma. Med Pediatr Oncol. 2002;38:91-97.
19. Blaser SI, Harwood-Nash DC. Neuroradiology of pediatric posterior fossa medulloblastoma. J Neurooncol. 1996;29:23-34.
20. Meyers SP, Wildenhain SL, Chang JK, et al. Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes. AJNR Am J Neuroradiol. 2000;21:1757-1765.
21. Krampla W, Schatzer R, Urban M, Newrkla S, Knosp E, Hruby W. Lumbar meningeal enhancement after surgery in the posterior cranial fossa: a normal finding in children? Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2002;174:1511-1515.
22. Fouladi M, Heideman R, Langsten JW, Kun LE, Thompson SJ, Gajjar A. Infectious meningitis mimicking recurrent medulloblastoma on magnetic resonance imaging. Case report. J Neurosurg. 1999;91:499-502.
23. Fouladi M, Chintagumpala M, Laningham FH, et al. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol. 2004;22:4551-4560.
24. Malviya S, Voepel-Lewis T, Eldevik OP, Rockwell DT, Wong JH, Tait AR. Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth. 2000;84:743-748.
25. Michalski J. Phase III randomized adjuvant study of standard-dose versus reduced-dose craniospinal radiotherapy and posterior fossa boost versus tumor bed boost radiotherapy in combination with chemotherapy comprising vincristine, cisplatin, lomustine and cyclophosphamide in pediatric patients with newly diagnosed standard-risk medulloblastoma. COG-ACNS0331 Children's Oncology Group. Available from URL: http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid= 365506&version=patient&protocolsearchid=2127676 Accessed on February 28, 2006.